Clinical trial
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
NCT04965506
Study timeline
Study start (actual)2021-09-06Date precision: day
Registry last updated2023-12-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetesunresolved
Interventions
Sponsors & collaborators
Innovent Biologics (Suzhou) Co. Ltd.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04965506 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.